Progyny Inc (NASDAQ: PGNY) kicked off on Friday, up 1.06% from the previous trading day, before settling in for the closing price of $14.19. Over the past 52 weeks, PGNY has traded in a range of $13.39-$42.08.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 61.75% over the past five years. While this was happening, its average annual earnings per share was recorded -13.23%. With a float of $71.52 million, this company’s outstanding shares have now reached $88.34 million.
Let’s look at the performance matrix of the company that is accounted for 566 employees. In terms of profitability, gross margin is 21.68%, operating margin of 5.75%, and the pretax margin is 7.18%.
Progyny Inc (PGNY) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Health Information Services Industry. The insider ownership of Progyny Inc is 16.01%, while institutional ownership is 91.55%. The most recent insider transaction that took place on Dec 09 ’24, was worth 627,648. Before that another transaction happened on Jul 16 ’24, when Company’s PRESIDENT sold 9,030 for $30.00, making the entire transaction worth $270,900. This insider now owns 362,583 shares in total.
Progyny Inc (PGNY) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.38 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -13.23% per share during the next fiscal year.
Progyny Inc (NASDAQ: PGNY) Trading Performance Indicators
Take a look at Progyny Inc’s (PGNY) current performance indicators. Last quarter, stock had a quick ratio of 2.62. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.08. Likewise, its price to free cash flow for the trailing twelve months is 7.69.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.58, a number that is poised to hit 0.09 in the next quarter and is forecasted to reach 0.59 in one year’s time.
Technical Analysis of Progyny Inc (PGNY)
Progyny Inc (NASDAQ: PGNY) saw its 5-day average volume 2.62 million, a positive change from its year-to-date volume of 1.42 million. As of the previous 9 days, the stock’s Stochastic %D was 15.31%. Additionally, its Average True Range was 0.64.
During the past 100 days, Progyny Inc’s (PGNY) raw stochastic average was set at 6.35%, which indicates a significant decrease from 22.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 43.49% in the past 14 days, which was lower than the 86.64% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $15.37, while its 200-day Moving Average is $24.40. Nevertheless, the first resistance level for the watch stands at $14.58 in the near term. At $14.82, the stock is likely to face the second major resistance level. The third major resistance level sits at $15.13. If the price goes on to break the first support level at $14.03, it is likely to go to the next support level at $13.72. The third support level lies at $13.48 if the price breaches the second support level.
Progyny Inc (NASDAQ: PGNY) Key Stats
The company with the Market Capitalisation of 1.23 billion has total of 85,153K Shares Outstanding. Its annual sales at the moment are 1,089 M in contrast with the sum of 62,040 K annual income. Company’s last quarter sales were recorded 286,630 K and last quarter income was 10,420 K.
